124 related articles for article (PubMed ID: 24763036)
21. Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.
Schulze A; Schirutschke H; Oelschlägel U; Schmitz M; Füssel M; Wassmuth R; Ehninger G; Bornhäuser M; Platzbecker U
Exp Hematol; 2008 Apr; 36(4):378-89. PubMed ID: 18261840
[TBL] [Abstract][Full Text] [Related]
22. A hybrid form of myeloid/NK-cell acute leukemia and myeloid/NK-cell precursor acute leukemia.
Sun T; Pashaei S; Jaffrey I; Ryder J
Hum Pathol; 2003 May; 34(5):504-8. PubMed ID: 12792926
[TBL] [Abstract][Full Text] [Related]
23. Transient myeloproliferative disorder with a CD7+ and CD56+ myeloid/natural killer cell precursor phenotype in a newborn.
Svaldi M; Moroder W; Messner H; Battisti L; Venturi R; Coser P; Mitterer M
J Pediatr Hematol Oncol; 2002; 24(5):394-6. PubMed ID: 12142790
[TBL] [Abstract][Full Text] [Related]
24. Acute leukemia with myeloid, B-, and natural killer cell differentiation.
Lee PS; Lin CN; Liu C; Huang CT; Hwang WS
Arch Pathol Lab Med; 2003 Feb; 127(2):E93-5. PubMed ID: 12562262
[TBL] [Abstract][Full Text] [Related]
25. Generation of functional natural killer and dendritic cells in a human stromal-based serum-free culture system designed for cord blood expansion.
Frias AM; Porada CD; Crapnell KB; Cabral JM; Zanjani ED; Almeida-Porada G
Exp Hematol; 2008 Jan; 36(1):61-8. PubMed ID: 18155552
[TBL] [Abstract][Full Text] [Related]
26. [Immunologic classification used in typing of 68 cases of acute leukemias].
Sun XL; Fang MY; Jiang F; Jing Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):39-41. PubMed ID: 16584588
[TBL] [Abstract][Full Text] [Related]
27. Natural killer cell receptor repertoire is comparable amongst newly diagnosed acute myeloid leukemia of different French-American-British subtypes, risk categories and chemosensitivities.
Ho X; Fook-Chong S; Linn YC
Leuk Lymphoma; 2014 Feb; 55(2):342-8. PubMed ID: 23550989
[TBL] [Abstract][Full Text] [Related]
28. Myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as FAB-M3 acute myeloid leukemia.
Paietta E; Gallagher RE; Wiernik PH
Blood; 1994 Oct; 84(8):2824-5. PubMed ID: 7522645
[No Abstract] [Full Text] [Related]
29. Extramedullary presentation of acute leukaemia: a case of myeloid/natural killer cell precursor leukaemia.
Chen VM; McIlroy K; Loui JP; Fay K; Ward C
Pathology; 2003 Aug; 35(4):325-9. PubMed ID: 12959763
[TBL] [Abstract][Full Text] [Related]
30. Importance of T-cell receptor delta-chain gene analysis on CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia.
Kimura N; Yoshida T; Nagano M; Tamura K
Blood; 1998 Apr; 91(7):2622-4. PubMed ID: 9516168
[No Abstract] [Full Text] [Related]
31. Secondary myeloid/natural killer cell precursor acute leukemia following essential thrombocythemia.
Nagai M; Bandoh S; Tasaka T; Fujita M; Yamauchi A; Kuwabara H; Funamoto Y; Yamaoka G; Takahara J
Hum Pathol; 1999 Jul; 30(7):868-71. PubMed ID: 10414508
[TBL] [Abstract][Full Text] [Related]
32. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry].
Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689
[TBL] [Abstract][Full Text] [Related]
33. Immunological classification of acute myeloblastic leukemias: relevance to patient outcome.
Casasnovas RO; Slimane FK; Garand R; Faure GC; Campos L; Deneys V; Bernier M; Falkenrodt A; Lecalvez G; Maynadié M; Béné MC
Leukemia; 2003 Mar; 17(3):515-27. PubMed ID: 12646939
[TBL] [Abstract][Full Text] [Related]
34. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
[TBL] [Abstract][Full Text] [Related]
35. The importance of CD7 and CD56 antigens in acute leukaemias.
Tiftik N; Bolaman Z; Batun S; Ayyildiz O; Isikdogan A; Kadikoylu G; Muftuoglu E
Int J Clin Pract; 2004 Feb; 58(2):149-52. PubMed ID: 15055863
[TBL] [Abstract][Full Text] [Related]
36. CD56-positive acute lymphoblastic leukemia.
Matano S; Terahata S; Nakamura S; Kobayashi K; Sugimoto T
Acta Haematol; 2005; 114(3):160-3. PubMed ID: 16227680
[TBL] [Abstract][Full Text] [Related]
37. [Cytomorphology of acute mixed leukemia].
Sucić M; Batinić D; Zadro R; Mrsić S; Labar B
Acta Med Croatica; 2008 Oct; 62(4):379-85. PubMed ID: 19205415
[TBL] [Abstract][Full Text] [Related]
38. CD56+/CD4+ lymphomas and leukemias are morphologically, immunophenotypically, cytogenetically, and clinically diverse.
Rakozy CK; Mohamed AN; Vo TD; Khatib G; Long PM; Eilender D; Palutke M
Am J Clin Pathol; 2001 Aug; 116(2):168-76. PubMed ID: 11488062
[TBL] [Abstract][Full Text] [Related]
39. Childhood myeloid/natural killer precursor acute leukemia with novel chromosomal aberrations der(5)t(4;5)(q31;q31.3) and t(14;17)(q32;q23).
Abdelhaleem M; Shago M; Sayeh E; Abla O
Cancer Genet Cytogenet; 2007 Oct; 178(2):141-3. PubMed ID: 17954270
[TBL] [Abstract][Full Text] [Related]
40. Leukemia-associated aberrant immunophenotype in patients with acute myeloid leukemia: changes at refractory disease or first relapse and clinicopathological findings.
Cui W; Zhang D; Cunningham MT; Tilzer L
Int J Lab Hematol; 2014 Dec; 36(6):636-49. PubMed ID: 24602197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
